Literature DB >> 3110217

Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle.

H Yki-Järvinen, D Mott, A A Young, K Stone, C Bogardus.   

Abstract

We examined the insulin dose-response characteristics of human muscle glycogen synthase and phosphorylase activation. We also determined whether increasing the rate of glucose disposal by hyperglycemia at a fixed insulin concentration activates glycogen synthase. Physiological increments in plasma insulin but not glucose increased the fractional activity of glycogen synthase. The ED50: s for insulin stimulation of whole body and forearm glucose disposal were similar and unaffected by glycemia. Glycogen synthase activation was exponentially related to the insulin-mediated component of whole body and forearm glucose disposal at each glucose concentration. Neither insulin nor glucose changed glycogen phosphorylase activity. These results suggest that insulin but not the rate of glucose disposal per se regulates glycogen synthesis by a mechanism that involves dephosphorylation of glycogen synthase but not phosphorylase. This implies that the low glycogen synthase activities found in insulin-resistant states are a consequence of impaired insulin action rather than reduced glucose disposal.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110217      PMCID: PMC442206          DOI: 10.1172/JCI113069

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Insulin-stimulated glycogen formation in rat diaphragm. Levels of tissue intermediates in short-time experiments.

Authors:  J LARNER; C VILLAR-PALASI; D J RICHMAN
Journal:  Arch Biochem Biophys       Date:  1960-01       Impact factor: 4.013

2.  The role of ATP and glucose 6-phosphate in the regulation of glycogen synthetase D phosphatase.

Authors:  D P Gilboe; F Q Nuttall
Journal:  Biochem Biophys Res Commun       Date:  1972-08-21       Impact factor: 3.575

3.  The influence of insulin and epinephrine on adenosine 3',5'-phosphate and glycogen transferase in muscle.

Authors:  J W Craig; T W Rall; J Larner
Journal:  Biochim Biophys Acta       Date:  1969-04-01

4.  Liver and muscle glycogen in man after glucose and fructose infusion.

Authors:  L H Nilsson; E Hultman
Journal:  Scand J Clin Lab Invest       Date:  1974-02       Impact factor: 1.713

5.  Importance of the hematocrit in interpretation of blood sugar.

Authors:  R S Dillon
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

6.  Hormonal effects on glycogen metabolism in the rat heart in situ.

Authors:  B J Williams; S E Mayer
Journal:  Mol Pharmacol       Date:  1966-09       Impact factor: 4.436

7.  Muscle glycogen in man determined in needle biopsy specimens: method and normal values.

Authors:  E Hultman
Journal:  Scand J Clin Lab Invest       Date:  1967       Impact factor: 1.713

8.  The glycogen synthase system in skeletal muscle of normal humans and patients with myotonic dystrophy: effect of glucose and insulin administration.

Authors:  F Q Nuttall; J Barbosa; M C Gannon
Journal:  Metabolism       Date:  1974-06       Impact factor: 8.694

9.  Glucose as a regulator of glycogen phosphorylase in rat diaphragm. I. Effect of glucose and related compounds on phosphorylase and glycogen levels.

Authors:  P A Holmes; T E Mansour
Journal:  Biochim Biophys Acta       Date:  1968-03-11

10.  Glucose as a regulator of glycogen phosphorylase in rat diaphragm. II. Effect of glucose and related compounds on phosphorylase phosphatase.

Authors:  P A Holmes; T E Mansour
Journal:  Biochim Biophys Acta       Date:  1968-03-11
View more
  34 in total

1.  The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes.

Authors:  J Giebelstein; G Poschmann; K Højlund; W Schechinger; J W Dietrich; K Levin; H Beck-Nielsen; K Podwojski; K Stühler; H E Meyer; H H Klein
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

2.  Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.

Authors:  A W Thorburn; B Gumbiner; F Bulacan; P Wallace; R R Henry
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Re-feeding after starvation involves a temporal shift in the control site of glycogen synthesis in rat muscle.

Authors:  A P James; C B Flynn; S L Jones; T N Palmer; P A Fournier
Journal:  Biochem J       Date:  1998-01-15       Impact factor: 3.857

4.  Stem cell therapy to treat diabetes mellitus.

Authors:  Chee Gee Liew; Peter W Andrews
Journal:  Rev Diabet Stud       Date:  2009-02-10

5.  Defective insulin response of cyclic adenosine monophosphate-dependent protein kinase in insulin-resistant humans.

Authors:  Y Kida; B L Nyomba; C Bogardus; D M Mott
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

6.  Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  A Vaag; P Damsbo; O Hother-Nielsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

7.  Assessment of proinsulin's effects on intermediary metabolism using the forearm technique in normal man.

Authors:  S N Davis; L Monti; P M Piatti; M Ansiferov; C Hetherington; M Brown; H Orskov; W Branch; C N Hales; K G Alberti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

8.  Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.

Authors:  H Shamoon; S Friedman; C Canton; L Zacharowicz; M Hu; L Rossetti
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 9.  Pathogenesis of insulin resistance in skeletal muscle.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Biomed Biotechnol       Date:  2010-04-26

10.  A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance.

Authors:  A B Goldfine; P R Conlin; F Halperin; J Koska; P Permana; D Schwenke; S E Shoelson; P D Reaven
Journal:  Diabetologia       Date:  2013-01-31       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.